It has been found that Interleukin 6 (IL-6) promotes epithelial-to-mesenchymal transition (EMT), stemness and chemoresistance in osteosarcoma cells through the hyperactivation of STAT3 through a mechanism mediated by osteopontin (OPN) [74]. The gene discussed is STAT3; the disease is osteosarcoma.